GlassScriptPhysician profile
Anastasius O Peter
NPI 1558320978
$46,483.72
in general payments reported to CMS, 2019-2025
15 companies · $5,858 in 2025
The $5,858 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $6,364 · 2021: $13K · 2022: $2,946 · 2024: $556 · 2025: $5,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,100 · Food and Beverage: $1,565 · Education: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,099.79 |
| Food and Beverage | $1,564.51 |
| Education | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $43,244.84 | 2019-2025 | |
| Distalmotion US | $1,750.71 | 2025 | Dexter L6 Robot |
| Medtronic, INC. | $352.31 | 2022-2024 | Signia, Dextile |
| Shockwave Medical, INC | $150.47 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Covidien LP | $140.56 | 2019 | |
| Baxter Healthcare | $125.00 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $111.00 | 2020 | |
| Heron Therapeutics, INC. | $109.62 | 2025 | Zynrelef |
| Davol INC. | $105.62 | 2022 | |
| Organogenesis INC. | $101.87 | 2025 | Puraply Wound Matrix |
| Biocomposites INC | $80.78 | 2025 | Stimulan |
| Mallinckrodt Hospital Products INC. | $77.01 | 2020 | |
| Mallinckrodt Enterprises LLC | $69.07 | 2019 | |
| Conmed Corporation | $39.47 | 2019 | |
| Mozarc Medical US LLC | $25.39 | 2024 | Argyle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anastasius Peter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.